Last reviewed · How we verify
Tuberculosis
Approved treatments
- Ftivazid
Ftivazid works by inhibiting the activity of myeloperoxidase, an enzyme that contributes to the development of tuberculosis. - RIFAMPIN
Rifampin inhibits DNA-dependent RNA polymerase activity in susceptible Mycobacterium tuberculosis organisms.
Pipeline
- CEPHALEXIN — Phase 2
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Tuberculosis patent landscape — cliff calendar, originator estates, attackable patents
- Tuberculosis treatment landscape brief
- Tuberculosis treatment updates RSS
Frequently asked questions about Tuberculosis
What drugs treat Tuberculosis?
Tracked treatments include Ftivazid, RIFAMPIN.
What is the treatment for Tuberculosis?
Standard treatment for Tuberculosis includes Ftivazid, RIFAMPIN. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Tuberculosis?
1 pipeline drugs tracked. Top candidates: CEPHALEXIN.
Related
- Treatment landscape: Tuberculosis patent cliff · Tuberculosis CI report
- Treatment: Ftivazid
- Treatment: RIFAMPIN
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing